166 related articles for article (PubMed ID: 37524630)
1. Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses.
Amani A; Njoh AA; Atuhebwe P; Ndoula S; Nembot R; Mbossou F; Tsague L; Adisso L; Bita Fouda AA; Gonese E; Perrault N; Habimana P; Saidu Y; Mirza I; Ntakarutimana D; Balde T; Mihigo R; Chaiban T; Gueye AS
Vaccine; 2023 Aug; 41(38):5572-5579. PubMed ID: 37524630
[TBL] [Abstract][Full Text] [Related]
2. The first 30 days of COVID-19 vaccination in Cameroon: achievements, challenges, and lessons learned.
Amani A; Djossaya D; Njoh AA; Fouda AAB; Ndoula S; Abba-Kabir HM; Mossus T; Nguefack-Tsague G; Kamgno J
Pan Afr Med J; 2022; 41():201. PubMed ID: 35685114
[TBL] [Abstract][Full Text] [Related]
3. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study.
Chen Z; Zheng W; Wu Q; Chen X; Peng C; Tian Y; Sun R; Dong J; Wang M; Zhou X; Zhao Z; Zhong G; Yan X; Liu N; Hao F; Zhao S; Zhuang T; Yang J; Azman AS; Yu H
BMC Med; 2022 Apr; 20(1):130. PubMed ID: 35369871
[TBL] [Abstract][Full Text] [Related]
4. Uncovering inequities in Covid-19 vaccine coverage for adults and elderly in Brazil: A multilevel study of 2021-2022 data.
Boing AF; Boing AC; Barberia L; Borges ME; Subramanian SV
Vaccine; 2023 Jun; 41(26):3937-3945. PubMed ID: 37221119
[TBL] [Abstract][Full Text] [Related]
5. An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey.
Ateudjieu J; Yakum MN; Goura AP; Tembei Ayok M; Guenou E; Kangmo Sielinou CB; Kiadjieu FF; Tsafack M; Douanla Koutio IM; Tchio-Nighie KH; Tchokomeni H; Ntsekendio PN; Sack DA
BMC Public Health; 2022 Feb; 22(1):238. PubMed ID: 35123444
[TBL] [Abstract][Full Text] [Related]
6. Challenges, best practices, and lessons learned from oral cholera mass vaccination campaign in urban Cameroon during the COVID-19 era.
Amani A; Ngo Bama S; Dia M; Nguefack Lekelem S; Linjouom A; Mossi Makembe H; Ateke Njoh A; Cheuyem Lekeumo FZ; Eyebe S; Nguefack-Tsague G; Kamgno J
Vaccine; 2022 Nov; 40(47):6873-6879. PubMed ID: 36270892
[TBL] [Abstract][Full Text] [Related]
7. Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel's COVID-19 vaccination program.
Rosen B; Waitzberg R; Israeli A; Hartal M; Davidovitch N
Isr J Health Policy Res; 2021 Aug; 10(1):43. PubMed ID: 34340714
[TBL] [Abstract][Full Text] [Related]
8. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A
Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930
[TBL] [Abstract][Full Text] [Related]
9. Disparities in COVID-19 vaccine uptake among rural hard-to-reach population and urban high-risk groups of Bangladesh.
Jannat Z; Das H; Ali MW; Wahed T; Alam MN; Uddin MJ
PLoS One; 2024; 19(4):e0302056. PubMed ID: 38683814
[TBL] [Abstract][Full Text] [Related]
10. Reactive mass vaccination campaign against cholera in the COVID-19 context in Cameroon: challenges, best practices and lessons learned.
Amani A; Fouda AAB; Nangmo AJ; Bama SN; Tatang CA; Mbang MA; Douba ECE; Noula AGM; Dia M; Bouhenia M
Pan Afr Med J; 2021; 38():392. PubMed ID: 34381536
[TBL] [Abstract][Full Text] [Related]
11. Using Location Intelligence to Evaluate the COVID-19 Vaccination Campaign in the United States: Spatiotemporal Big Data Analysis.
Li Q; Peng JC; Mohan D; Lake B; Euler AR; Weir B; Kan L; Yang C; Labrique A
JMIR Public Health Surveill; 2023 Feb; 9():e39166. PubMed ID: 36626835
[TBL] [Abstract][Full Text] [Related]
12. Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study.
Bor J; Assoumou SA; Lane K; Diaz Y; Ojikutu BO; Raifman J; Levy JI
PLoS Med; 2023 Jan; 20(1):e1004167. PubMed ID: 36719864
[TBL] [Abstract][Full Text] [Related]
13. Accelerating into Immunization Agenda 2030 with momentum from China's successful COVID-19 vaccination campaign during dynamic COVID Zero.
Rodewald LE
Infect Dis Poverty; 2023 Oct; 12(1):96. PubMed ID: 37845759
[TBL] [Abstract][Full Text] [Related]
14. Disparities in child and adolescent COVID-19 vaccination coverage and parental intent toward vaccinations for their children and adolescents.
Nguyen KH; Levisohn A; McChesney C; Vasudevan L; Bednarczyk RA; Corlin L
Ann Med; 2023 Dec; 55(1):2232818. PubMed ID: 37449878
[TBL] [Abstract][Full Text] [Related]
15. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
16. Incidence and types of adverse events during mass vaccination campaign with the meningococcal a conjugate vaccine (MENAFRIVAC™) in Cameroon.
Ateudjieu J; Stoll B; Nguefack-Tsague G; Yakum MN; Mengouo MN; Genton B
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1170-1178. PubMed ID: 27174237
[TBL] [Abstract][Full Text] [Related]
17. Catch-up vaccination campaign in children between 6 and 8 years old during COVID-19 pandemic: The experience in a COVID hub in Milan, Italy.
Mancarella M; Natarelli F; Bertolini C; Zagari A; Enrica Bettinelli M; Castaldi S
Vaccine; 2022 Jun; 40(26):3664-3669. PubMed ID: 35570078
[TBL] [Abstract][Full Text] [Related]
18. A retrospective review of vaccine wastage and associated risk factors in the Littoral region of Cameroon during 2016-2017.
Nkenyi R; Pak GD; Tonga C; Chon Y; Park SE; Kang S
BMC Public Health; 2022 Oct; 22(1):1956. PubMed ID: 36274145
[TBL] [Abstract][Full Text] [Related]
19. [Safety of delayed vaccination with the national immunization program vaccines in children aged 0-6 years from 2019 to 2021 in Xuhui District, Shanghai City in China].
Wu QS; Mao SQ; Xu Y; Gong RJ; Zhou Q; Liu M; Liu JY; Zhu DH; Guo X
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jul; 57(7):983-991. PubMed ID: 37482734
[No Abstract] [Full Text] [Related]
20. Evaluation of a COVID-19 Vaccine Campaign and SARS-CoV-2 Infection and Mortality Among Adults Aged 60 Years And Older in a Middle-Income Country.
Macchia A; Ferrante D; Angeleri P; Biscayart C; Mariani J; Esteban S; Tablado MR; de Quirós FGB
JAMA Netw Open; 2021 Oct; 4(10):e2130800. PubMed ID: 34714342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
